Hydrocodone Bitartrate is a potent Active Pharmaceutical Ingredient (API) in the therapeutic category of pain management and antitussive agents, synthesized and purified at Parand Darou Pharmaceutical Company in compliance with the most reputable international pharmacopeial standards, including the British Pharmacopoeia (BP) and United States Pharmacopeia (USP).
Quality Standards & Specifications
This compound features a high purity level of at least 99.0% and an assay range of 99.0% to 101.0% on an anhydrous basis. Strict control of physicochemical parameters, including acidity (pH 3.2 to 3.8), water content (7.0% to 12.0%), and specific optical rotation (-87° to -91°), ensures optimal efficacy, bioavailability, and safety for pharmaceutical product manufacturing.
Physical Properties & Storage Conditions
Hydrocodone Bitartrate is supplied as a white or almost white, hygroscopic crystalline powder that is freely soluble or soluble in water. Due to its sensitivity to humidity and light, storage in airtight containers protected from direct light is mandatory to maintain its stability for at least two years at room temperature.
General Information
| Product Name | Hydrocodone Bitartrate | |
| Chemical Name | 4,5α-Epoxy-3-methoxy-17-methylmorphinan-6-one hydrogen (2R,3R)-2,3-dihydroxybutanedioate 2.5-hydrate | |
| Manufacturer | Parand Darou Co. | |
| CAS No. | 34195-34-1 | |
| Category | Pain management | |
| Pharmacopoeia | BP, USP |
Specification
| Molecular formula |
Specification
|
